Evidence map›Paper›PMID 30985241›Full record

ArticleInfectious diseases (London, England)2019

Biofilm formation by Staphylococcus aureus clinical isolates correlates with the infection type.

Jakub M Kwiecinski, Gunnar Jacobsson, Alexander R Horswill, Elisabet Josefsson, Tao Jin

Abstract read
In one paragraph

Article in Infectious diseases (London, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Bacterial and host interactions inFrontiers in microbiology · 2025
    Review
  4. Article
  5. Article
  6. TheMicroorganisms · 2024
    Article
  7. Exploration ofFrontiers in cellular and infection microbiology · 2024
    Article
  8. Article
  9. Article
  10. Genomic epidemiology and characterization ofFrontiers in microbiology · 2023
    Article
  11. StaphylococcalInternational journal of molecular sciences · 2022
    Article
  12. Biofilm Formation ofAntibiotics (Basel, Switzerland) · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Frontiers in microbiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jakub M Kwiecinskia Department of Rheumatology and Inflammation Research , Institute of Medicine, Sahlgrenska Academy, University of Gothenburg , Gothenburg , Sweden.
Gunnar Jacobssonc Department of Infectious Diseases , Skaraborg Hospital , Skövde , Sweden.
Alexander R Horswillb Department of Immunology and Microbiology , University of Colorado School of Medicine , Aurora , CO , USA.
Elisabet Josefssona Department of Rheumatology and Inflammation Research , Institute of Medicine, Sahlgrenska Academy, University of Gothenburg , Gothenburg , Sweden.
Tao Jina Department of Rheumatology and Inflammation Research , Institute of Medicine, Sahlgrenska Academy, University of Gothenburg , Gothenburg , Sweden.

Funding

The S. aureus biofilm lifecycleP01AI083211 · NIAID · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI THOMAS, VINAI · 2009 to 2023
$32.1M
Quorum Sensing Dependent Interactions with Biofilms and Innate Immunity DefensesI01BX002711 · VA · VA EASTERN COLORADO HEALTH CARE SYSTEM · PI ALEXANDER R HORSWILL · 2015 to 2026
–
BLRD VA I01 BX002711NIAID NIH HHS P01 AI083211
6 · The paper itself

Abstract

backgroundBiofilms are involved in many Staphylococcus aureus infections, but relation of biofilm formation and the infection types or the clinical outcomes remain unclear.

methodsWe measured biofilm formation, with a microtiter plate assay, of a collection of methicillin-sensitive clinical isolates from 159 invasive S. aureus infections, encompassing all cases occurring within a hospital catchment area during two years, and from additional 49 non-invasive skin infections from the same region. Results were related to available clinical and microbiological documentation.

resultsIsolates from medical device infections (intravenous line-associated and prosthetic joint infections), as well as isolates from superficial skin infections, were particularly proficient in forming biofilms. No increased biofilm-forming capacity was seen in isolates from endocarditis, osteomyelitis, or other infections. There was also a correlation of biofilm formation with the agr type of the isolates. Thicker biofilms were more resistant to antibiotic treatment in vitro. No correlation between biofilm formation and clinical outcomes was noted.

conclusionsS. aureus isolates from 'classical' biofilm-related infections, but also from superficial skin infections, are especially proficient in forming biofilms. There is, however, no obvious relation of biofilm-forming capacity of isolates and the clinical outcome of the infection, and more studies on this issue are needed.

Indexed as

Anti-Bacterial AgentsBacterial ProteinsBiofilmsGenotypeHumansMethicillin-Resistant Staphylococcus aureusSkin DiseasesStaphylococcal InfectionsStaphylococcus aureusTrans-ActivatorsAgr protein, Staphylococcus aureusAnti-Bacterial AgentsBacterial ProteinsTrans-Activatorsantibiotic sensitivityBiofilmclinical outcomeskin

Identifiers

PMID30985241
PMCPMC7153559

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.